BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pediatric Endocrine Society - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pediatric Endocrine Society
X-ORIGINAL-URL:https://pedsendo.org
X-WR-CALDESC:Events for Pediatric Endocrine Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260623T150000
DTEND;TZID=America/New_York:20260623T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27784-1782226800-1782230400@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-06-23/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260615T170000
DTEND;TZID=America/New_York:20260615T180000
DTSTAMP:20260521T194400Z
CREATED:20260521T194212Z
LAST-MODIFIED:20260521T194400Z
UID:27626-1781542800-1781546400@pedsendo.org
SUMMARY:Diabetes Type 2 SIG Meeting
DESCRIPTION:For more information on the Diabetes Type 2 SIG\, click here. \nTo join the SIG\, please click here.
URL:https://pedsendo.org/event/diabetes-type-2-sig-meeting/2026-06-15/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260609T181500
DTEND;TZID=America/New_York:20260609T191500
DTSTAMP:20260518T194935Z
CREATED:20260518T145500Z
LAST-MODIFIED:20260518T194935Z
UID:27465-1781028900-1781032500@pedsendo.org
SUMMARY:PES Podcast Club: Genetic Data From Over 20\,000 U.S. Children Misused for 'Race Science'
DESCRIPTION:Revised PES_Podcast_Club_Flyer \nTuesday\, June 9\, 2026 at 6:15 PM Eastern \nThis Session’s Topic: \n“Genetic Data From Over 20\,000 U.S. Children Misused for ‘Race Science'” \nNew York Times audio article · January 24\, 2026 · ~20 min listen \nnytimes.com/2026/01/24/us/children-genetics-race-science.html \nPlease join the PES Health Systems & Disparities Committee for a virtual Podcast Club on Tuesday\, June 9\, 2026\, at 6:15 PM Eastern. This moderated community discussion will focus on the New York Times audio article\, “Genetic Data From Over 20\,000 U.S. Children Misused for ‘Race Science.’” \nThe 20-minute audio piece raises important questions about research ethics\, community trust\, race as a social versus biological construct\, and the responsibility of scientific and medical communities to advocate for ethical data governance. Participants are encouraged to listen to the article in advance and come prepared for a thoughtful discussion with HSD colleagues across PES. \nThe session will be facilitated by Dr. Ilene Fennoy\, MD\, MPH. All PES members are welcome.
URL:https://pedsendo.org/event/pes-podcast-club-genetic-data-from-over-20000-u-s-children-misused-for-race-science/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260604T170000
DTEND;TZID=America/New_York:20260604T180000
DTSTAMP:20260212T153714Z
CREATED:20251113T143434Z
LAST-MODIFIED:20260212T153714Z
UID:26483-1780592400-1780596000@pedsendo.org
SUMMARY:PES Thyroid SIG Webinar\, Pediatric Thyroid US Series: 2. Abnormal Thyroid US.
DESCRIPTION:Thursday\, June 4\, 2026\, 5-6pET – State of the Art: Thyroid SIG \nSession Title: Pediatric Thyroid US Series 2: Abnormal Thyroid US. \nBrief Description: \nThis is a 3 part series on the Pediatric Thyroid US. This second session is focused on Abnormal Thyroid US \nLearning Objectives   \n\nIdentify features of thyroid diseases\, benign thyroid nodules\, and cancer.\nEvaluation of cervical lymph nodes for metastatic involvement.\nBecome familiar with TIRADS classification.\nReview Indications for FN\n\n  \nSpeaker Name(s)  \nDr. Wasserman
URL:https://pedsendo.org/event/pes-thyroid-sig-webinar-pediatric-thyroid-us-series-2-abnormal-thyroid-us/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260602T120000
DTEND;TZID=America/New_York:20260602T130000
DTSTAMP:20251110T181648Z
CREATED:20251110T181648Z
LAST-MODIFIED:20251110T181648Z
UID:26428-1780401600-1780405200@pedsendo.org
SUMMARY:PES SEED Webinar: Turner syndrome/Klinefelter syndrome
DESCRIPTION:Date: Tuesday\, June 2\, 2026\, 12:00 PM EST \nTitle: Turner syndrome/Klinefelter syndrome \nBrief Description: \nThis interactive lecture explores two key sex chromosome aneuploidies — Turner syndrome (45\,X) and Klinefelter syndrome (47\,XXY). Students will learn about the genetic and chromosomal basis of each condition\, their characteristic physical and reproductive features\, underlying pathophysiology\, diagnostic methods (including karyotyping and hormonal assays)\, and management strategies. The session will also highlight the psychosocial and developmental implications of these syndromes\, emphasizing the importance of early diagnosis\, multidisciplinary care\, and genetic counseling. \nLearning objectives: \n1. Describe the chromosomal abnormalities and genetic mechanisms underlying Turner syndrome (45\,X) and Klinefelter syndrome (47\,XXY).\n2. Identify the key clinical features\, endocrine findings\, and complications associated with each condition\n3. Discuss the principles of diagnosis\, management\, and genetic counseling\, including the role of Multidisciplinary care \n Speaker: \nNandini Vijayakanthi MBBS FAAP\nAssistant Professor of Pediatrics\nSection of Pediatric Endocrinology/Department of Pediatrics\nWake Forest University School of Medicine /Brenner Children’s Hospital\nWinston Salem\, North Carolina
URL:https://pedsendo.org/event/pes-seed-webinar-turner-syndrome-klinefelter-syndrome/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260526T150000
DTEND;TZID=America/New_York:20260526T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27783-1779807600-1779811200@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-05-26/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260430T120000
DTEND;TZID=America/New_York:20260430T130000
DTSTAMP:20260519T214044Z
CREATED:20250821T150935Z
LAST-MODIFIED:20260519T214044Z
UID:26067-1777550400-1777554000@pedsendo.org
SUMMARY:PES APP SIG Meeting
DESCRIPTION:For more information on the APP SIG\, click here. \nTo join a SIG\, click here.
URL:https://pedsendo.org/event/pes-app-sig-meeting-2/2026-04-30/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260430
DTEND;VALUE=DATE:20260504
DTSTAMP:20260204T190830Z
CREATED:20250123T181117Z
LAST-MODIFIED:20260204T190830Z
UID:24987-1777507200-1777852799@pedsendo.org
SUMMARY:2026 Annual Meeting
DESCRIPTION:April 30- May 3\, 2026 \nSan Francisco\, CA
URL:https://pedsendo.org/event/2026-annual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260428T150000
DTEND;TZID=America/New_York:20260428T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27782-1777388400-1777392000@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-04-28/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260415T170000
DTEND;TZID=America/New_York:20260415T180000
DTSTAMP:20260311T160154Z
CREATED:20260203T214018Z
LAST-MODIFIED:20260311T160154Z
UID:26954-1776272400-1776276000@pedsendo.org
SUMMARY:PES Hypoglycemia SIG Webinar: Diagnosis and Management of Ketotic Hypoglycemia
DESCRIPTION:Wednesday\, April 15\, 2026\, 5-6pET – State of the Art: Hypoglycemia SIG  \nSession Title: Diagnosis and Management of Ketotic Hypoglycemia \nBrief Description: \nThis seminar will review how patients normally respond to fasting and how ketones are produced. It will help clinicians distinguish normal (physiologic) ketotic hypoglycemia from disease-related causes. The session will cover when and how to evaluate patients\, how to interpret key labs\, and practical approaches to treatment and prevention. Case examples will be used to support day-to-day clinical decision-making. \nLearning Objectives   \n\nDistinguish between ketotic and nonketotic forms of hypoglycemia\nDistinguish between physiologic and pathologic ketotic hypoglycemia\nLearn management strategies for various forms of ketotic hypoglycemia\n\nSpeaker Name \nDr. Joseph Wolfsdorf\, Boston Children’s Hospital
URL:https://pedsendo.org/event/pes-hypoglycemia-sig-webinar-diagnosis-and-management-of-ketotic-hypoglycemia/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260414T173000
DTEND;TZID=America/New_York:20260414T183000
DTSTAMP:20260325T161722Z
CREATED:20260203T213858Z
LAST-MODIFIED:20260325T161722Z
UID:26952-1776187800-1776191400@pedsendo.org
SUMMARY:PES Ethics SIG Webinar: Ethics Case-Based Discussion - Spring Edition
DESCRIPTION:Tuesday\, April 14\, 2026\, 5:30-6:30pET – State of the Art: Ethics SIG  \nSession Title: Ethics Case-Based Discussion – Spring Edition \nBrief Description: \nJoin the PES Ethics SIG for a discussion of clinical cases that raise ethical questions. PES members are invited to submit cases with ethical dilemmas to present for discussion for this webinar. \nCases should be submitted to camilia_kamoun@med.unc.edu by April 8\, 2026. Two to three cases will be selected for presentation. \nLearning Objectives   \n\nIdentify ethical dilemmas in pediatric endocrinology\nDescribe ethical approaches to clinical care in pediatric endocrinology\nDefine key ethical principles to guide clinical care in pediatric endocrinology\n\nSpeaker Name \nCamilia Kamoun
URL:https://pedsendo.org/event/pes-ethics-sig-webinar-ethics-case-based-discussion-spring-edition/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260407T180000
DTEND;TZID=America/New_York:20260407T190000
DTSTAMP:20260305T140522Z
CREATED:20260305T140522Z
LAST-MODIFIED:20260305T140522Z
UID:27237-1775584800-1775588400@pedsendo.org
SUMMARY:PES Hypoglycemia SIG Meeting
DESCRIPTION:Mission Statement \nHypoglycemia disorders are rare\, but their consequences in children can be severe and have a lasting impact. The PES Hypoglycemia Disorders Special Interest Group (SIG) aims to improve the diagnosis and management of infants and children with hypoglycemia disorders through education\, clinical care standardization\, research and advocacy. \n  \nTo Learn more about the SIG\, click here. \nTo join the SIG\, click here.
URL:https://pedsendo.org/event/pes-hypoglycemia-sig-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260324T150000
DTEND;TZID=America/New_York:20260324T170000
DTSTAMP:20260311T143435Z
CREATED:20260203T213729Z
LAST-MODIFIED:20260311T143435Z
UID:26950-1774364400-1774371600@pedsendo.org
SUMMARY:PES TREND SIG & PedsEndo 365 Webinar: Evaluation and Management of Tumor Related Endocrine and Neuroendocrine Disorders
DESCRIPTION:Tuesday\, March 24\, 2026\, 3-5pET – State of the Art: TREND SIG & PedsEndo 365 \nSession Title: \nEvaluation and Management of Tumor Related Endocrine and Neuroendocrine Disorders\nBrief Description: \nIn collaboration with the Tumor Related Endocrine and Neuroendocrine Disorders (“TREND”) SIG\, the PedsEndo365 aims to improve increased awareness of late effects observed in childhood cancer and brain tumor survivors through a case-based workshop for pediatric endocrinology fellows. \nLearning Objectives   \n\nUnderstand the complex interplay between hypothalamic disruption associated with intracranial radiation with or without surgery\nDescribe the effect/s of chemotherapy on gonadal function in both males and females\nDiscuss the mechanisms by which tyrosine kinase inhibitors and immune check point inhibitors impact the endocrine system\n\nSpeaker Name \n\nPriyanka Bakhtiani\nKanthi Bangalore Krishna\nNidhi Bansal\nWassim Chemaitilly\nLaurie Cohen\nPallavi Iyer\nAmit Lahoti\nMaya Lodish\nAlison Murray\nJessica Schmidt\nCarmen L. Soto-Rivera
URL:https://pedsendo.org/event/pes-trend-sig-pedsendo-365-webinar-evaluation-and-management-of-dsd/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260324T150000
DTEND;TZID=America/New_York:20260324T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27781-1774364400-1774368000@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-03-24/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260321T080000
DTEND;TZID=America/New_York:20260325T163000
DTSTAMP:20251105T142459Z
CREATED:20251027T165819Z
LAST-MODIFIED:20251105T142459Z
UID:26332-1774080000-1774456200@pedsendo.org
SUMMARY:Clinical Endocrinology 2026 Course
DESCRIPTION:The objective of this course is to provide an update for endocrinologists and to allow internists and other health care providers to be comfortable with clinical problems in endocrinology. A faculty of 49 speakers\, primarily Harvard Medical School faculty and several select outside experts\, chosen for their recognized educational and communication skills\, present the most up-to-date\, evidence-based approach to endocrine problems such as osteoporosis\, type 1 and type 2 diabetes\, hypercholesterolemia\, pituitary tumors\, menopause\, thyroid abnormalities\, and reproductive dysfunction\, as well as a broad spectrum of other clinical problems in endocrinology\, such as obesity. Each day is organized around one of the major topics to be covered: pituitary disease on Saturday; calcium and bone disorders on Sunday; diabetes and metabolic disorders on Monday; reproductive and adrenal disorders on Tuesday; thyroid disease on Wednesday. Special emphasis is given to the case study method in 90-minute problem sessions on Sunday\, Monday\, and Tuesday. Two of these sessions will include a nurse or nurse practitioner to provide a nursing perspective on the topic. A comprehensive syllabus is provided; all companies providing educational grants are acknowledged in the syllabus and thanked during the Welcome & Introduction session. \nFor more than 50 years\, this update in Endocrinology has been presented by the faculty of the Endocrine Division of Massachusetts General Hospital\, joined by guest speakers from around the country. Attendees have participated from over 50 US states and territories\, and over 60 other countries. The virtual livestream format enhances access to the course for international health care providers. Course participants are asked to fill out an extensive evaluation form that covers all aspects of the course. \nLink for faculty\, learning objectives and more information – https://learn.hms.harvard.edu/endocrinology \nCME- earn up to 40.5 AMA PRA Category 1 Credits™\, ABIM MOC points\, ANCC contact hours\, AAPA Category 1 Credits\, and ECME Credits
URL:https://pedsendo.org/event/an-invitation-from-the-harvard-medical-school-massachusetts-general-hospital-clinical-endocrinology-2026-course/
LOCATION:https://pedsendo.org/event/an-invitation-from-the-harvard-medical-school-massachusetts-general-hospital-clinical-endocrinology-2026-course/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260316T160000
DTEND;TZID=America/New_York:20260316T170000
DTSTAMP:20250818T200222Z
CREATED:20250818T200222Z
LAST-MODIFIED:20250818T200222Z
UID:26051-1773676800-1773680400@pedsendo.org
SUMMARY:Quarterly Education Webinar: Thyroid cancer in children and adolescents
DESCRIPTION:Date: Monday\, March 16\, 2026 / 4:00 pm – 5:00 pm EST \nTitle: Thyroid cancer in children and adolescents\n \nDescription: This session will review thyroid cancer in children and adolescents. \nLearning objectives: \n\nDiscuss the epidemiology and genetics of thyroid cancer in children\nDiscuss diagnosis of thyroid cancer in children\nExplain current approaches to thyroid cancer treatment in children\n\nSpeaker: \nAri Wassner\, MD; Harvard Medical School\, Boston Children’s Hospital
URL:https://pedsendo.org/event/quarterly-education-webinar-thyroid-cancer-in-children-and-adolescents/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260311T190000
DTEND;TZID=America/New_York:20260311T200000
DTSTAMP:20260203T213508Z
CREATED:20260203T213508Z
LAST-MODIFIED:20260203T213508Z
UID:26948-1773255600-1773259200@pedsendo.org
SUMMARY:PES State of the Art Webinar;  Incorporating patient advocates into the DSD/Intersex Multidisciplinary Clinics
DESCRIPTION:Wednesday\, March 11\, 2026\, 7-8pET – State of the Art: DSD SIG \nSession Title: Incorporating patient advocates into the DSD/Intersex Multidisciplinary Clinics \nBrief Description: \nThis session will focus on the incorporation of patient advocates into the Intersex/DSD multidisciplinary clinics. The session will be open to members of PES and members of the Society of Pediatric Psychology. It will be lead by Cindy Buchanan\, PhD and Noi Liang\, MBA\, BCPA who have developed a patient advocate program. Our goals are to help Intersex/DSD multidisciplinary clinics develop a patient advocate programs and to continue facilitate the collaboration between pediatric endocrinologist\, pediatric psychologists\, and patient advocates. \nLearning Objectives   \n\nDescribe the role of the patient advocates in intersex/DSD MDC and Identify ways to engage patients and care givers\nUnderstand steps for identifying and training patient advocates\nReview the experience of the patient advocate\n\nSpeaker Name \nCindy Buchanan\, PhD \nNoi Liang\, MBA\, BCPA
URL:https://pedsendo.org/event/pes-state-of-the-art-webinar-incorporating-patient-advocates-into-the-dsd-intersex-multidisciplinary-clinics/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260311T150000
DTEND;TZID=America/New_York:20260311T160000
DTSTAMP:20260218T173108Z
CREATED:20260218T173108Z
LAST-MODIFIED:20260218T173108Z
UID:27089-1773241200-1773244800@pedsendo.org
SUMMARY:Industry Sponsored Symposium: Real-World Patient and Clinical Perspectives: Preparing Your Pediatric Patients for Successful Care Transitions in Classic Congenital Adrenal Hyperplasia
DESCRIPTION:Industry Sponsored Symposium:\nReal-World Patient and Clinical Perspectives: Preparing Your Pediatric Patients for Successful Care Transitions in Classic Congenital Adrenal Hyperplasia\n \nWednesday\, March 11\, 2026 at 3:00 – 4:00pm ET\nSponsored by Neurocrine BioSciences \nDescription:\nFeaturing insights from a patient\, caregiver\, and an expert healthcare provider and researcher\, this presentation highlights the clinical and practical challenges involved in the lifelong management of classic congenital adrenal hyperplasia. The speakers will share valuable takeaways from their own experiences navigating the transition from pediatric to adult endocrinology care. \nAttendees will learn about the risks associated with transitions of care\, including adrenal crisis and gaps in disease management\, and discover strategies for early planning\, patient empowerment\, and standardized hand-off protocols. \nSpeakers: \nLeslie Pitts\, DNP-PhD(c)\, CPNP-AC\, AP-PEN\nUniversity of Alabama at Birmingham\nSchool of Nursing \nKevin\nA 26-year-old living with classic congenital adrenal hyperplasia and patient ambassador \nTrish\nKevin’s mother and caregiver ambassador \nSponsored by: Neurocrine BioSciences
URL:https://pedsendo.org/event/industry-sponsored-symposium-real-world-patient-and-clinical-perspectives-preparing-your-pediatric-patients-for-successful-care-transitions-in-classic-congenital-adrenal-hyperplasia/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260303T120000
DTEND;TZID=America/New_York:20260303T130000
DTSTAMP:20251110T170319Z
CREATED:20251110T165324Z
LAST-MODIFIED:20251110T170319Z
UID:26421-1772539200-1772542800@pedsendo.org
SUMMARY:PES SEED Webinar: Evaluation and Management of Common Endocrine Emergencies
DESCRIPTION:Date: Tuesday\, March 3\, 2026\, 12:00 PM EST \nTitle: Evaluation and Management of Common Endocrine Emergencies \nBrief Description: \nSEED talk re endocrine emergencies \nLearning objectives: \n1. Review emergent medical conditions of endocrine origin\n2. Discuss the evaluation for endocrine emergencies\, including which clinical presentations raise concern for an endocrine emergency\n3. Describe management of endocrine emergencies \n Speaker: \nNancie MacIver\nAssociate Professor of Pediatrics\, Nutrition\, and Microbiology/Immunology\nDivision Chief\, Pediatric Endocrinology\nUniversity of North Carolina at Chapel Hill
URL:https://pedsendo.org/event/26421/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260226T170000
DTEND;TZID=America/New_York:20260226T180000
DTSTAMP:20260218T200658Z
CREATED:20251113T143002Z
LAST-MODIFIED:20260218T200658Z
UID:26480-1772125200-1772128800@pedsendo.org
SUMMARY:PES Thyroid SIG Webinar\, Pediatric Thyroid US Series - Session 1 - Normal Thyroid US
DESCRIPTION:Thursday\, February 26\, 2026\, 5-6pET – State of the Art: Thyroid SIG \nSession Title: Pediatric Thyroid US Series – Session 1 – Normal Thyroid US \nBrief Description: \nThis is a 3 part series on the Pediatric Thyroid US. This first session is focused on Normal Thyroid US. \nLearning Objectives   \n\nIdentify features of normal thyroid anatomy and normal variations (e.g.\, intrathyroidal thymus)\nIdentify features of normal thyroid anatomy (e.g.\, intrathyroidal thymus) and normal variations\nDescribe features of autoimmune thyroid conditions and differentiate nodules from pseudonodules\nPractical tips for incorporating thyroid US into daily endocrine practice\n\nSpeaker Name(s)  \nDr. Andrew Bauer
URL:https://pedsendo.org/event/pes-thyroid-sig-webinar-pediatric-thyroid-us-series-1-normal-thyroid-us/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260224T150000
DTEND;TZID=America/New_York:20260224T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27780-1771945200-1771948800@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-02-24/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260218T130000
DTEND;TZID=America/New_York:20260218T140000
DTSTAMP:20251219T193221Z
CREATED:20251113T151043Z
LAST-MODIFIED:20251219T193221Z
UID:26499-1771419600-1771423200@pedsendo.org
SUMMARY:PES DSD SIG Webinar: Gonadal Management in DSD
DESCRIPTION:Wednesday\, February 18\, 2026\, 1-2pET – State of the Art: DSD SIG \nSession Title: Gonadal Management in DSD \nBrief Description: \nIndividuals with various forms of differences of sex development (DSD) may be at increased risk of developing gonadal germ cell cancer. This risk depends on several factors including the presence of the gonadoblastoma region on the Y chromosome\, gonadal location\, degree of gonadal dysgenesis\, degree of germ cell development and age\, but only limited data are available on cancer incidence\, especially in adulthood. This presentation will go into assessment of gonadal cancer risk as well as gonadal function. Current options for gonadal monitoring will be reviewed\, acknowledging their limitations. Individuals with DSD and their families should be counseled about the options for gonadal monitoring or prophylactic gonadectomy to allow shared decision making regarding gonadal management; tools have been developed to facilitate this process. \nLearning Objectives   \n\nDifferentiate between gonads at higher or lower risk for gonadal germ cell cancer in individuals with DSD\nCompare the potential benefits and harms or risks of gonadal monitoring versus prophylactic gonadectomy\nSummarize the steps of shared decision-making regarding gonadal management\n\n  \nSpeaker Name(s)  \nSabine Hannema\, MD\, PhD \nDepartment of Paediatric Endocrinology\, \nEmma Children’s Hospital\, Amsterdam UMC\, \nAmsterdam\, the Netherlands
URL:https://pedsendo.org/event/pes-dsd-sig-webinar-management-of-the-risky-gonad-in-individuals-with-dsd/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260211T160000
DTEND;TZID=America/New_York:20260211T170000
DTSTAMP:20260130T185324Z
CREATED:20260130T184439Z
LAST-MODIFIED:20260130T185324Z
UID:26925-1770825600-1770829200@pedsendo.org
SUMMARY:PES Ethics SIG: Beyond the Algorithm: Ethical AI in Pediatric Endocrinology
DESCRIPTION:Wednesday\, February 11\, 2026\, 4-5pET – State of the Art: Ethics SIG \nSession Title: Beyond the Algorithm: Ethical AI in Pediatric Endocrinology \nBrief Description: \nArtificial intelligence is rapidly transforming how we practice medicine—from clinical decision support and documentation to patient communication and diagnostic reasoning. As pediatric endocrinologists\, we face unique opportunities and challenges as these tools enter our workflows. How do we integrate AI responsibly? Where are the risks? And what does ethical practice look like when humans and algorithms collaborate? \nJoin the Ethics SIG for a dynamic conversation on the ethical implications of AI in pediatric endocrinology\, guided by Kelly Michelson\, MD\, MPH\, FCCM\, FAAP\, HEC-C—Professor of Pediatrics\, Julia & David Uihlein Professor of Bioethics and Medical Humanities\, Director of the Center for Bioethics and Medical Humanities\, and Chief Ethics Officer for the Institute for Augmented Intelligence in Medicine at Northwestern University Feinberg School of Medicine. \nThis session will explore how AI can support care\, where it may hinder it\, and how pediatric endocrinologists can navigate these rapidly evolving tools with clarity\, caution\, and creativity. \nLearning Objectives   \n\nIdentify current and emerging uses of AI relevant to pediatric endocrine practice.\nAnalyze ethical challenges and potential biases in AI tools\, particularly as they affect children and adolescents with endocrine disorders.\nEvaluate real-world scenarios illustrating how AI may shape clinical judgment\, patient communication\, and provider responsibility.\nApply practical strategies for incorporating AI into practice while preserving professionalism\, patient trust\, and equitable care.\n\n  \nSpeaker Name(s)  \nKelly Michelson\, MD\, MPH\, FCCM\, FAAP\, HEC-C
URL:https://pedsendo.org/event/pes-ethics-sig-beyond-the-algorithm-ethical-ai-in-pediatric-endocrinology/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260211T120000
DTEND;TZID=America/New_York:20260211T130000
DTSTAMP:20251110T165405Z
CREATED:20251110T164100Z
LAST-MODIFIED:20251110T165405Z
UID:26418-1770811200-1770814800@pedsendo.org
SUMMARY:PES SEED Webinar: Calcium Pathophysiology/Management
DESCRIPTION:Date: Wednesday\, February 11\, 2026\, 12:00 PM EST \nTitle: Calcium Pathophysiology/Management \nBrief Description: \nSEED lecture for medical students re calcium\, speaker Monica Grover from Stanford \nLearning objectives: \n1. Describe common conditions that can impact calcium and phosphorus physiology\n2. Review the impacts of parathyroid hormone and vitamin D on calcium physiology\n3. Discuss management strategies for acute and chronic hypocalcemia and hypercalcemia \n Speaker: \nMonica Grover\nClinical Associate Professor of Pediatrics\,\nDivision of Endocrinology and Diabetes\nStanford University School of Medicine
URL:https://pedsendo.org/event/pes-seed-webinar-calcium-pathophysiology-management/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260211T103000
DTEND;TZID=America/New_York:20260211T113000
DTSTAMP:20260123T144634Z
CREATED:20260120T163458Z
LAST-MODIFIED:20260123T144634Z
UID:26817-1770805800-1770809400@pedsendo.org
SUMMARY:Industry Sponsored Symposium: Exploring Innovative Pathways for Congenital Hyperinsulinism Treatment Pioneering Pathways to Better Health
DESCRIPTION:Industry Sponsored Symposium:\nExploring Innovative Pathways for Congenital Hyperinsulinism Treatment Pioneering Pathways to Better Health \nWednesday\, February 11\, 2026 at 10:30 am – 11:30 am ET \nDescription:\nCongenital hyperinsulinemia (CHI) is a complex and serious disorder that most often appears in newborns and young infants as prolonged\, often severe\, hypoglycemia. When diagnosis or treatment is delayed or inadequate\, infants face a real risk of irreversible neurological damage\, therefore\, timely recognition and prompt intervention are essential. \nCurrent medical and surgical options are limited\, leaving many families with few effective choices. New therapies on the horizon may change that landscape — offering options for easier administration\, less frequent dosing\, improved tolerability\, and with a promise of reduced frequency and duration of hypoglycemia. \nJoin our live webinar where leading experts will confront the critical gaps in CHI care\, review real patient cases and outcomes\, and evaluate both established treatments and emerging therapies. You’ll gain practical\, evidence-based insights to improve early detection\, optimize management\, and better support families affected by this challenging disease. \nCME/CNE available. \nModerator: ​​ \nJulie Raskin\, ​Chief Executive Officer\, ​Congenital Hyperinsulinism International\, Glen Ridge\, New Jersey​ \nSpeaker: \nDiva D. De Leon Crutchlow\, MD\, MSCE\, Division Chief: Endocrinology and Diabetes Children’s Hospital of Philadelphia Professor of Pediatrics University of Pennsylvania Philadelphia\, Pennsylvania \nPaul S. Thornton\, MD\, ​Division Chief\, Endocrinology and Diabetes\, Cook Children’s Medical Center\, ​Fort Worth\, Texas​ \nSponsored by: Supported by an independent educational grant from Zealand Pharma A/S.
URL:https://pedsendo.org/event/industry-sponsored-symposium-exploring-innovative-pathways-for-congenital-hyperinsulinism-treatment-pioneering-pathways-to-better-health/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260209T160000
DTEND;TZID=America/New_York:20260209T170000
DTSTAMP:20251113T141306Z
CREATED:20251111T141531Z
LAST-MODIFIED:20251113T141306Z
UID:26463-1770652800-1770656400@pedsendo.org
SUMMARY:PES Bone&Mineral Webinar: New\, Disruptive Precision Therapies for Achondroplasia: Changing the Rules of the Game
DESCRIPTION:Monday\, February 9\, 2026\, 4-5pET – State of the Art: Bone and Mineral SIG \nSession Title: New\, Disruptive Precision Therapies for Achondroplasia: Changing the Rules of the Game \nBrief Description: \nThis presentation will discuss newly approved and emerging pharmacotherapies for the treatment of achondropDISABLEDlasia. Special attention will be given to potential benefits of these treatments on clinically important and patient centered outcomes beyond stature including quality of life and sequelae of spinal stenosis\, foramen magnum stenosis\, and other orthopedic manifestations of this condition. Given the recent approval of vosoritide and anticipated approval of other pharmacotherapies targeting the FGFR3 pathway for the treatment of achondropDISABLEDlasia\, we anticipate that this topic will be of interest to a wide range of the PES community who will be participating in the care of these individuals. \nLearning Objectives   \n\nUnderstand the pathophysiology underlying achondroplasia\nLearn how the current and emerging pharmacotherapies for achondroplasia target the FGFR3 pathway\nBecome familiar with possible benefits of treatment on outcomes beyond height\n\n  \nSpeaker Name(s)  \nProfessor Ravi Savarirayan\,\nInterventional Clinical Geneticist\,\nMurdoch Children’s Research Institute\,\nUniversity of Melbourne\, Parkville\, Victoria\, Australia
URL:https://pedsendo.org/event/pes-bonemineral-webinar-new-disruptive-precision-therapies-for-achondroplasia-changing-the-rules-of-the-game/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260209T120000
DTEND;TZID=America/New_York:20260209T130000
DTSTAMP:20260519T214044Z
CREATED:20250821T150935Z
LAST-MODIFIED:20260519T214044Z
UID:26066-1770638400-1770642000@pedsendo.org
SUMMARY:PES APP SIG Meeting
DESCRIPTION:For more information on the APP SIG\, click here. \nTo join a SIG\, click here.
URL:https://pedsendo.org/event/pes-app-sig-meeting-2/2026-02-09/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260205T180000
DTEND;TZID=America/New_York:20260205T190000
DTSTAMP:20260123T193134Z
CREATED:20251107T195343Z
LAST-MODIFIED:20260123T193134Z
UID:26415-1770314400-1770318000@pedsendo.org
SUMMARY:PES Turner Syndrome SIG Webinar: Prenatal Counseling for Turner Syndrome
DESCRIPTION:Thursday\, February 5\, 2026\, 6-7pET – State of the Art: Turner Syndrome SIG \nSession Title: Prenatal Counseling for Turner Syndrome \nBrief Description: \nSpeaker will discuss prenatal genetic counseling strategies and spectrum in Turner syndrome. Case based discussion. \nLearning Objectives   \n\nUnderstand the landscape and principles of genetic counseling for prenatal diagnoses of Turner syndrome\nApplication of these principles in a case based format\nReview post-natal genetic testing\n\n  \nSpeaker Name(s)  \nWendy Brickman\, MD \nSusan Howell\, MBA\, MS\, CGC
URL:https://pedsendo.org/event/pes-turner-syndrome-sig-webinar-prenatal-counseling-for-turner-syndrome/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260203T120000
DTEND;TZID=America/New_York:20260203T130000
DTSTAMP:20260209T175539Z
CREATED:20250818T181201Z
LAST-MODIFIED:20260209T175539Z
UID:26046-1770120000-1770123600@pedsendo.org
SUMMARY:Understanding the impact of bias and stigma on children affected by obesity
DESCRIPTION:Tuesday\, February 3\, 2026\, 12-1pET – State of the Art: Obesity SIG & HSD Committee \nSession Title: Understanding the impact of bias and stigma on children affected by obesity \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBrief Description:\n\n\nBias and stigma have been shown to be common experiences of individuals affected by obesity. Understanding the impact of bias and stigma on children. the role of internalized stigma and how to recognize it\, as well as the interventions identified or proposed to improve the outcomes for our patients will be discussed. \nLearning objectives:  \n\nDescribe how weight bias affects the emotional and physical health of children and adolescents.\n2. Explain the role of families—particularly parents—in shaping youth experiences of weight stigma.\nIdentify practical strategies pediatric clinicians can use to reduce weight bias in patient care for youth with higher weight.\n\nSpeaker:  \nRebecca Puhl\, PhD Professor\, Human Development & Family Sciences Deputy Director\, Rudd Center for Food Policy & Health University of Connecticut 
URL:https://pedsendo.org/event/understanding-the-impact-of-bias-and-stigma-on-children-affected-by-obesity/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260127T170000
DTEND;TZID=America/New_York:20260127T180000
DTSTAMP:20251111T133832Z
CREATED:20251111T133745Z
LAST-MODIFIED:20251111T133832Z
UID:26449-1769533200-1769536800@pedsendo.org
SUMMARY:PES Hypoglycemia SIG Webinar: Demystifying the Fasting Test
DESCRIPTION:Tuesday\, January 27\, 2026\, 5-6pET – State of the Art: Hypoglycemia SIG \nSession Title: \nDemystifying the Fasting Test \nBrief Description:\nThe diagnostic evaluation of an infant or child that presents with hypoglycemia is a critical step for establishing the specific diagnosis and treatment. This evaluation relies on obtaining a “critical sample” during a spontaneous episode of hypoglycemia or at the end of diagnostic fast. Fasting tests are also performed to establish the efficacy of the treatment\, or the resolution of the hypoglycemia after definitive treatment. During this webinar we will review the practical aspects of performing these different fasting tests\, the interpretation of the results\, and the safety of the procedure. \nLearning objectives: \n\nTo review the indications for diagnostic\, safety\, and cure fasting tests\nTo outline the differences between diagnostic\, safety and cure fasting tests\nTo review the interpretation of data obtained during diagnostic\, safety and cure fasting tests\n\nSpeakers: \nKatherine Lord\, MD\nChildren’s Hospital of Philadelphia \nPaul Thornton\, MD\nCook Children’s Medical Center
URL:https://pedsendo.org/event/26449/
END:VEVENT
END:VCALENDAR